Literature DB >> 23832243

Carbon-11 radiolabeling of iron-oxide nanoparticles for dual-modality PET/MR imaging.

Ramesh Sharma1, Youwen Xu, Sung Won Kim, Michael J Schueller, David Alexoff, S David Smith, Wei Wang, David Schlyer.   

Abstract

Dual-modality imaging, using Magnetic Resonance Imaging (MRI) and Positron Emission Tomography (PET) simultaneously, is a powerful tool to gain valuable information correlating structure with function in biomedicine. The advantage of this dual approach is that the strengths of one modality can balance the weaknesses of the other. However, success of this technique requires developing imaging probes suitable for both. Here, we report on the development of a nanoparticle labeling procedure via covalent bonding with carbon-11 PET isotope. Carbon-11 in the form of [(11)C]methyl iodide was used as a methylation agent to react with carboxylic acid (-COOH) and amine (-NH2) functional groups of ligands bound to the nanoparticles (NPs). The surface coating ligands present on superparamagnetic iron-oxide nanoparticles (SPIO NPs) were radiolabeled to achieve dual-modality PET/MR imaging capabilities. The proof-of-concept dual-modality PET/MR imaging using the radiolabeled SPIO NPs was demonstrated in an in vivo experiment.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23832243     DOI: 10.1039/c3nr02519e

Source DB:  PubMed          Journal:  Nanoscale        ISSN: 2040-3364            Impact factor:   7.790


  17 in total

Review 1.  Engineering of radiolabeled iron oxide nanoparticles for dual-modality imaging.

Authors:  Fanrong Ai; Carolina A Ferreira; Feng Chen; Weibo Cai
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2015-12-22

Review 2.  Dawn of advanced molecular medicine: nanotechnological advancements in cancer imaging and therapy.

Authors:  Charalambos Kaittanis; Travis M Shaffer; Daniel L J Thorek; Jan Grimm
Journal:  Crit Rev Oncog       Date:  2014

Review 3.  Radiolabeled inorganic nanoparticles for positron emission tomography imaging of cancer: an overview.

Authors:  Rubel Chakravarty; Shreya Goel; Ashutosh Dash; Weibo Cai
Journal:  Q J Nucl Med Mol Imaging       Date:  2017-01-26       Impact factor: 2.346

Review 4.  Targeted PET/MRI Imaging Super Probes: A Critical Review of Opportunities and Challenges.

Authors:  Anna Kastelik-Hryniewiecka; Pawel Jewula; Karolina Bakalorz; Gabriela Kramer-Marek; Nikodem Kuźnik
Journal:  Int J Nanomedicine       Date:  2022-01-01

Review 5.  Positron emission tomography and nanotechnology: A dynamic duo for cancer theranostics.

Authors:  Shreya Goel; Christopher G England; Feng Chen; Weibo Cai
Journal:  Adv Drug Deliv Rev       Date:  2016-08-09       Impact factor: 15.470

Review 6.  Nanoparticles and radiotracers: advances toward radionanomedicine.

Authors:  Edwin C Pratt; Travis M Shaffer; Jan Grimm
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2016-03-23

Review 7.  Multimodality Imaging Agents with PET as the Fundamental Pillar.

Authors:  Dalong Ni; Emily B Ehlerding; Weibo Cai
Journal:  Angew Chem Int Ed Engl       Date:  2018-12-11       Impact factor: 15.336

Review 8.  Multimodal Composite Iron Oxide Nanoparticles for Biomedical Applications.

Authors:  Shameer Pillarisetti; Saji Uthaman; Kang Moo Huh; Yang Seok Koh; Sangjoon Lee; In-Kyu Park
Journal:  Tissue Eng Regen Med       Date:  2019-10-01       Impact factor: 4.169

Review 9.  Nuclear molecular imaging with nanoparticles: radiochemistry, applications and translation.

Authors:  D S Abou; J E Pickett; D L J Thorek
Journal:  Br J Radiol       Date:  2015-07-02       Impact factor: 3.039

10.  Radiolabeling of Nanoparticles and Polymers for PET Imaging.

Authors:  Katharina Stockhofe; Johannes M Postema; Hanno Schieferstein; Tobias L Ross
Journal:  Pharmaceuticals (Basel)       Date:  2014-04-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.